NCT04416607View on ClinicalTrials.gov

Corifollitropin Alpha and Ovarian Response

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 15, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Infertility, Female
Interventions
DRUG

Corifollitropin Alfa

Primary outcome measure is ovarian response measured by FORT. Drugs are administrated for controlled ovarian stimulation prior in vitro fertilization.

DRUG

Menotropins

Primary outcome measure is ovarian response measured by FORT. Drugs are administrated for controlled ovarian stimulation prior in vitro fertilization.

Trial Locations (2)

90001003

Centro de Reproduçao Humana Insemine, Porto Alegre

90003051

Hospital de Clinicas de Porto Alegre, Porto Alegre

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT04416607 - Corifollitropin Alpha and Ovarian Response | Biotech Hunter | Biotech Hunter